Tigermed (300347.CN/03347.HK) - Q3 Performance Recovered with Optimistic Future Development
This article analyzed Tigermed's business, growth potential, global layout, equity investment and also made forecast and rating for this company.
333 Views
Insights On China Healthcare Policy - 4+7: New Volume-Based Purchasing Policy
This article analyzedĀ Chinaās revolutionary volume-based purchasing policy, its impact on domestic healthcare companies and related investment...
533 Views
Tigermed IPO: Trading Debut
Hangzhou Tigermed Consulting (H) (3347 HK) is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
506 Views
Tigermed IPO: Valuation Insights
Hangzhou Tigermed Consulting (H) (3347 HK)Ā is a global contract research organisation (CRO). Tigermed is the largest clinical CRO in China with a...
535 Views
ECM Weekly (26 July 2020) - Li Auto, Ant Financial, Tigermed, Mindspace, Blue Moon
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. The...
627 Views